Tag Archives: Europe

Commercialization, Specialty Drug, Specialty HUBs

Idorsia Ltd. Strengthens Commercialization Collaboration with Syneos Health

Posted on by John Santilli
26
Jan

Idorsia Ltd. and Syneos Health® announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and Canada

Continue reading →
Specialty Drug, Specialty Pharmacy

Tanner Pharma Group Increasing Product Access With Named Patient Programs

Posted on by John Santilli
06
Oct

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country

Continue reading →